News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brenner Erin K.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Sold 8,690 shares
@ $1.13, valued at
$9.8k
|
|
| 01/18/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Exercised 22,000 restricted stock units
@ $0 |
|
| 12/09/2022 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Exercised 15,000 options to buy
@ $1, valued at
$15k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.|
Txns:
| Granted 52,520 options to buy
@ $4.06, valued at
$213.2k
Granted 66,667 restricted stock units
@ $0 |
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|